Stay updated on Mepolizumab Efficacy in Severe Asthma Clinical Trial

Sign up to get notified when there's something new on the Mepolizumab Efficacy in Severe Asthma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mepolizumab Efficacy in Severe Asthma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The two screenshots depict the same ClinicalTrials.gov page for NCT04228588 with no additions or deletions to core study content; any differences are limited to minor visual/format changes in layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:00:23.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    4%
    Check dated 2025-10-06T05:13:25.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Minor update: version bumped to v3.1.0 and new contact details added; previous v3.0.2 revision removed.
    Difference
    0.1%
    Check dated 2025-09-29T03:00:00.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:06:29.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T15:11:45.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically adding information about São Paulo, Brazil, and the medication mepolizumab, while removing previous location terms and references to genetic disease resources.
    Difference
    3%
    Check dated 2025-08-31T11:46:53.000Z thumbnail image

Stay in the know with updates to Mepolizumab Efficacy in Severe Asthma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mepolizumab Efficacy in Severe Asthma Clinical Trial page.